Rebus Pharmaceutical LLP
About Rebus Pharmaceutical LLP
Data last updated:
Rebus Pharmaceutical LLP is a limited liability partnership (LLP) based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 June 2016 and has been in existence for over 10 years.
The LLP is registered with the Registrar of Companies (ROC), Kolkata, under LLPIN AAG-6149. Its GSTIN is 19AAUFR2155B1Z2 (West Bengal).
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Bina Rajkumar Damani and Mayank Raj Kumar Damani.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at 28/1/A Ratan Sarkar Garden Street, Kolkata, West Bengal, India – 700007.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address28/1/A Ratan Sarkar Garden Street, Kolkata, West Bengal, India – 700007
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Rebus Pharmaceutical LLP FY 2025 filings available
Financial Statement Summary of Rebus Pharmaceutical LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Rebus Pharmaceutical LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Rebus Pharmaceutical are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Rebus Pharmaceutical LLP
Rebus Pharmaceutical has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bina Rajkumar Damani Also directs: Staark Stock Vision LLP | Designated Partner | 09 Jun 2016 | 10 Years 4 Months | Current |
| Mayank Raj Kumar Damani | Designated Partner | 09 Jun 2016 | 10 Years 4 Months | Current |
Charges & Borrowings of Rebus Pharmaceutical LLP
Rebus Pharmaceutical LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Rebus Pharmaceutical LLP
Employment history and EPFO contributions of people linked to Rebus Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Rebus Pharmaceutical LLP
Rebus Pharmaceutical LLP has 2 designated partner changes on record since 2016: 2 appointments. The latest: Bina Rajkumar Damani was appointed as Designated Partner on 09 Jun 2016.
Credit Ratings, Litigation & Regulatory Alerts for Rebus Pharmaceutical LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Rebus Pharmaceutical LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Rebus Pharmaceutical LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Rebus Pharmaceutical LLP
Rebus Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAUFR2155B1Z2 | West Bengal | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Rebus Pharmaceutical LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rebus Pharmaceutical LLP
Rebus Pharmaceutical is an active limited liability partnership based in Kolkata, West Bengal, India. The LLP works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 June 2016 (10+ years old) and is registered under LLPIN AAG-6149.
Rebus Pharmaceutical has 2 current designated partners:
- Bina Rajkumar Damani - Designated Partner
- Mayank Raj Kumar Damani - Designated Partner
The GSTIN of Rebus Pharmaceutical is 19AAUFR2155B1Z2, registered in West Bengal.
The LLPIN (Limited Liability Partnership Identification Number) of Rebus Pharmaceutical is AAG-6149. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Rebus Pharmaceutical was incorporated on 09 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Kolkata.
Bina Rajkumar Damani was appointed as Designated Partner on 09 Jun 2016. Mayank Raj Kumar Damani was appointed as Designated Partner on 09 Jun 2016.
The registered office of Rebus Pharmaceutical is at 281A Ratan Sarkar Garden Street, Kolkata, West Bengal, India – 700007.
The total obligation of contribution is ₹1 Lakh.
Rebus Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Rebus Pharmaceutical can be reached at its registered office: 281A Ratan Sarkar Garden Street, Kolkata, West Bengal, India – 700007.